Hoerger, Thomas J.; Bala, Mohan V.; Rowland, Clayton; … - In: PharmacoEconomics 14 (1998) 5, pp. 541-557
Objective: Pramipexole was recently approved in the US for treatment of the symptoms of idiopathic Parkinson's disease (PD). Although pramipexole has been found to be safe and efficacious when compared with placebo, little data are yet available on its cost effectiveness when compared with...